IDEXX Reference Laboratories

Cat sitting on windowsill.


A new method for managing and monitoring phosphorous overload in chronic kidney disease.

Early detection of phosphorous overload and metabolic bone disease in cats with IRIS CKD Stage 1 and Stage 21,2

Enables confident treatment recommendations, such as introducing a phosphate-restrictive diet

Enhanced view of a patient's kidney health — as an addition to IDEXX's suite of kidney health diagnostics, including the IDEXX SDMA Test

Contact us


  1. Geddes RF, Elliott J, Syme HM.  Relationship between Plasma Fibroblast Growth Factor-23 concentration and Survival Time in Cats with Chronic Kidney Disease.  J Vet Intern Med. 2015;29:1494-1501.
  2. Finch NC, Geddes RF, Syme HM, Elliott J.  Fibroblast Growth Factor 23 (FGF-23) Concentrations in Cats with Early Nonazotemic Chronic Kidney Disease (CKD) and in Health Geriatric Cats.  J Vet Intern Med.  2013;27:227-233